Clinical Trial Update: Does Erythropoietin Improve Outcome in Very Preterm Infants? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether erythropoietin improves outcomes in very preterm infants; completed study with conditions including intracranial hemor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Developmental Psychomotor Disorders
• Intracranial Hemorrhage
• Periventricular Leukomalacia

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Swiss Neonatal Network | Conditions: Intracranial Hemorrhage, Periventricular Leukomalacia | Phase 2 | Status: COMPLETED